Quantcast
Last updated on April 16, 2014 at 14:08 EDT

Latest Growth hormone releasing hormone Stories

2014-04-11 23:03:27

According to the U.S Food and Drug Administration (FDA), Americans spent an estimated $30 billion a year in 1992 on varied types of diet programs, weight loss regimen, including diet foods and drinks. Leading marketer of HGH, MetroMD Institute of Regenerative Medicine, recommends the use of HGH Sermorelin for body builders and fitness enthusiasts. Los Angeles, CA (PRWEB) April 11, 2014 According to the U.S Food and Drug Administration (FDA), Americans spent an estimated $30 billion a year...

2014-01-16 08:27:31

Growth Hormone Releasing Peptides and Growth Hormone Releasing Hormones offer legal, safe, inexpensive and effective benefits MILLBURN, N.J., Jan. 16, 2014 /PRNewswire/ -- Human Growth Hormone (HGH) produced by recombinant gene technology has been used extensively for anti-aging therapy during the past decade. Some of the symptoms of low HGH levels include a declining sex drive, lower energy levels, drowsy, sleepiness and fatigue, an accumulation of body fat and adipose tissue around the mid...

2013-01-18 08:23:29

MIAMI, Jan. 18, 2013 /PRNewswire/ -- Biscayne Pharmaceuticals, Inc. today announced that it has closed a $1.5 million financing. The new company is developing novel growth hormone-releasing hormone (GHRH) drugs based on recent discoveries by the company's scientific advisor, Dr. Andrew V. Schally, a world-renowned drug researcher and Nobel laureate who pioneered the field of hypothalamic peptide drugs. Biscayne also announced that it has exclusively licensed intellectual property from the...

2012-10-18 07:25:37

QUEBEC CITY, Oct. 18, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that Phase 3 results for its ghrelin agonist, AEZS-130, show that it has promise as a safe and simple oral diagnostic test for adult growth hormone deficiency (AGHD), with accuracy comparable to available testing procedures. Results were presented earlier today by George R. Merriam, MD, Director of the Clinical Study Unit at the VA Puget Sound Health Care...